SCHEMBL5834860

SCHEMBL5834860

CCN(CC)c1ccc(NC(=O)N(C(=O)OCc2ccccc2)C2CCc3ccccc3C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.55
NPY5R Q15761 2/20 0.51
NOX1 Q9Y5S8 2/20 0.47
NPY1R P25929 1/20 0.42
NPY2R P49146 1/20 0.42
RAB9A P51151 4/20 0.42
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 3/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5834802 0.90 GHSR (0.59) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5835382 0.89 GHSR (0.57) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5834787 0.87 GHSR (0.55) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5835198 0.87 GHSR (0.55) GHSRNPY5RNOX1RAB9ANPC1
SCHEMBL5835311 0.87 GHSR (0.55) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5835145 0.87 GHSR (0.55) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5835739 0.86 GHSR (0.64) GHSRNPY5RNOX1RAB9ANPC1
SCHEMBL5835103 0.86 GHSR (0.54) GHSRNPY5RNOX1NPY1RNPY2R
SCHEMBL5835266 0.86 GHSR (0.54) GHSRNPY5RNOX1RAB9ANPC1
SCHEMBL5834890 0.85 GHSR (0.58) GHSRNPY5RNOX1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885NPY5R 43/4885NOX1 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.